The QualityStocks Daily Wednesday, July 14th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(BHPA) $1.9000 +46.15%

MarketClub Analysis(DTSS) $3.9800 +35.84%

Zacks(COR) $5.0000 +24.07%

The QualityStocks Daily Stock List

Nova Lifestyle (NVFY)

TraderPower, StockMarketWatch, The Bowser Report, SmallCap Network, Wall Street Mover, TopPennyStockMovers, MarketClub Analysis, Promotion Stock Secrets, TradersPro, BUYINS.NET, INO Market Report, Investopedia, Jason Bond, MarketBeat, Marketbeat.com, Money Morning, QualityStocks, Stock Market Watch, Zacks, StockOodles, StreetAuthority Daily, Top Pros' Top Picks and Stock Beast reported earlier on Nova Lifestyle (NVFY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Commerce, California and was incorporated in 1992 by Yuen Ching Ho and Ya Ming Wong. Prior to its name change, the firm was known as Stevens Resources Inc. It operates as part of the manufacturing industry, in the consumer discretionary sector under the home and office products sub-industry.

The company has three companies in its corporate family and its products are sold in Australia, Europe, China, the United States and other markets across the globe. It distributes its products through online marketing campaigns and internet sales, retail stores and distributors in China, participation in trade shows and exhibitions, mainly to furniture retailers and distributors as well as directly under the Wo Zhi Bao, 1SOFA, Bright Swallow, Giorgio Mobili, Colorful World and Diamond Sofa brands.

The enterprise develops metal, wood-based and upholstered residential furniture for the dining, living and bed rooms, as well as home offices. Its product portfolio is made up of cupboards, cabinets, entertainment consoles, beds, dining tables, chairs and sofas as well as nova qwik products.

The company recently debuted a new furniture line at the High Point Market through its subsidiary. The High Point Market is the biggest home furnishing industry trade show globally. The move will promote sales as well as extend the company’s consumer reach, which will help bring in more investors into the firm.

Nova Lifestyle (NVFY), closed Wednesday’s trading session at $3.39, off by 6.6116%, on 1,228,766 volume. The average volume for the last 3 months is 408,988 and the stock's 52-week low/high is $1.45000004/$7.48999977.

Euro Tech Holdings Company (CLWT)

StockMarketWatch, MarketClub Analysis, QualityStocks, BUYINS.NET, OTCtipReporter, Penny Pick Finders, PennyStockScholar, PoliticsAndMyPortfolio, Jet-Life Penny Stocks, OTCPicks, TraderPower, PennyStockProphet, SmallCapVoice, Profitable Trader Authority, Investing Futures, HotOTC, Equity Observer, Momentum Traders, OnPointStockAlert, OTCBB Journal, Hot Stock Profits, Greenbackers, Broad Street, PennyStockRumors.net, Wall Street Mover, Small Cap Firm, SmallCapNetwork, Stock Traders Chat, StockHotTips, StockOnion, TopPennyStockMovers, TradersPro, Value Penny Stocks and Penny Stock Titans reported earlier on Euro Tech Holdings Company (CLWT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Hong Kong, the People’s Republic of China and was incorporated in 1996, on September 30th. It operates as part of the industrials sector, in the industrial services industry under the industrial support services sub-industry. The majority of the firm’s revenue is generated from Hong Kong.

The company operates through the engineering and trade and manufacturing segments. The former segment is involved in developing, engineering, producing, selling and servicing of environmental protection equipment and is also involved in the sale of water and wastewater related process control, supplies, disinfection equipment, testing and analytical instruments and related automation systems. On the other hand, the trade and manufacturing segment is engaged in the provision of power generation equipment, test kits, analyzers and lab instruments.

The enterprise distributes general testing and measuring equipment and also sells analytical instruments like atomic spectrometers, flow injector analyzers and chromatographs; sample pre-treatment equipment; and environmental monitoring instruments which include water and air quality monitoring instruments. In addition to this, it distributes supervisory control and data acquisition systems and software, telemetry units and programmable logic controllers. The enterprise sells its products via its website.

The company recently declared a special dividend which signifies exceptionally strong company earnings. This is a positive for the firm’s shareholders and may encourage more investments into the firm.

Euro Tech Holdings Company (CLWT), closed Wednesday’s trading session at $4.25, off by 1.8476%, on 720,996 volume. The average volume for the last 3 months is 349,709 and the stock's 52-week low/high is $1.50000095/$5.71000003.

Galiano Gold (GAU)

Stockhouse reported earlier on Galiano Gold (GAU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Vancouver, Canada and was incorporated in 1999, on September 23rd by Shawn Kristen Wallace and Ivan James Bebek. Prior to its name change in May 2020, the firm was known as Asanko Gold Inc. It operates in the materials sector, under the metals and mining sub-industry. The firm operates through the Ghana and Canada geographical segments and serves consumers in Canada.

The company’s objective is to become a cash generative, mid-tier gold mining firm via its flagship multi-million-ounce mine, which is located in Ghana, West Africa. It plans to do this through the implementation of a 3-pronged strategy, centered on capital costs and growth; both M&A and organic, competitive operating and phased production. This multi-deposit complex has 2 main deposits, i.e. Esaase and Nkran, as well as 9 satellite deposits, which are being developed in phases.

The enterprise’s primary asset is the Asanko Gold Mine, located in Ghana. It also holds interests in the ABG Mali property which is located on the Senegal-Mali shear zone and holds 4 gold exploration licenses which cover roughly 170 km.

The company recently appointed a new CEO and president. The move will allow the firm to realize full value for its stakeholders while also enabling them to consider opportunities that will boost the company’s growth in a manner that enhances shareholder investment, which will in turn bring in more investors into the firm.

Galiano Gold (GAU), closed Wednesday’s trading session at $1.05, up 0.961538%, on 399,922 volume. The average volume for the last 3 months is 991,711 and the stock's 52-week low/high is $1.00999999/$2.11999988.

Meta Materials (MMAT)

We reported earlier on Meta Materials (MMAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Dartmouth, Canada and was incorporated in 2021, on June 23rd by Themos Kallos and George Palikaras. It operates as part of the materials sector, under the chemicals sub-industry and serves consumers across the globe.

The enterprise specializes in the manufacture of highly functional films that have been engineered at the nanoscale to harness electromagnetic waves and the power of light. Its technology platform comprises of 3 core capabilities, namely wireless sensing, lithography and holography. This allows the enterprise to develop a library of functional prototypes and solutions at lower costs and at a much faster pace than traditional chemical synthesis. The enterprise serves the 5G communications, health and wellness, consumer electronics, clean energy, aerospace and defense and automotive industries across the globe and has sales as well as research and development offices in the Silicon Valley and London.

The company’s sustainable higher performance multi-use products employ the use of lightweight raw materials and processes to provide superior performance and consume less energy. Its products include a holographic optical component known as holoOPTIX; a revolutionary transparent conductive film dubbed NANOWEB; and a laser glare protection eyewear known as metaAIR. In addition to this, the company also develops Glucowise.

The firm recently concluded a project to develop a non-invasive glucose sensing prototype which can accurately predict changes in glucose level in diabetes patient. The prototype eliminates the need to draw blood in order to measure glucose levels. Its success will not only benefit patients with diabetes but also extend the firm’s consumer reach, which will be good for investments.

Meta Materials (MMAT), closed Wednesday’s trading session at $4.27, up 7.0175%, on 39,847,951 volume. The average volume for the last 3 months is 19.607M and the stock's 52-week low/high is $0.422199994/$21.7600002.

Golden Minerals (AUMN)

MarketBeat, StockMarketWatch, The Street, MonsterStocksPicks, TradersPro, InvestorPlace, Streetwise Reports, QualityStocks, Stock Stars, Lebed.biz, Investopedia, HotOTC, Greenbackers, Dynamic Wealth Report, CRWEWallStreet, PennyStockVille, CRWEPicks, CRWEFinance, CoolPennyStocks, Cabot Wealth, BUYINS.NET, BullRally, DrStockPick, StockEgg, Wall Street Mover, TopStockAnalysts, TopPennyStockMovers, StreetInsider, Street Insider, PennyInvest, StockHotTips, MadPennyStocks, Stock Beast, ProfitableTrading, PennyToBuck, Zacks, PennyOmega, BestOtc and StockRich reported earlier on Golden Minerals (AUMN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The firm has its headquarters in Golden, Colorado and was incorporated in 1996. Prior to its name change in March 2009 as a result of reorganization, the firm was known as Apex Silver Mines Limited. It operates in the materials sector, under the metals and mining sub-industry.

The company’s dealings are divided into 2 categories; its non-revenue producing activities which include administrative, general, construction and exploration activities and its Velardena Properties in Mexico. It explores for lead, zinc, silver and gold, as well as other minerals and also seeks to acquire operating or advanced mining properties. The company is focused mainly on properties in Mexico selected for near-term production potential, low development costs and high grades.

The enterprise’s portfolio comprises of the Sand Canyon silver-gold project in northwest Nevada; the El Quevar silver property which is located in the province of Salta, Argentina; the Yoquivo gold-silver project located in Chihuahua, Mexico; the Rodeo Property gold project located in the state of Durango in Mexico; and the Chicago and Velardena oxide and sulfide processing plants and precious metals mining properties in Durango State, Mexico. It holds 100% interest in every property and project mentioned above.

The company recently announced positive results from its ongoing expansion drill program at its Rodeo property. Increasing the life of the mine would mean more revenue for the firm, which not only helps keep the business alive but also helps advance its other projects, which will in turn bring in additional revenue and boost investments into the firm.

Golden Minerals (AUMN), closed Wednesday’s trading session at $0.5707, off by 3.6468%, on 608,066 volume. The average volume for the last 3 months is 823,790 and the stock's 52-week low/high is $0.380899995/$1.29999995.

Enertopia Corp. (ENRT)

QualityStocks, PennyStocks24, Shiznit Stocks, Penny Stock General, MassiveStockProfits, Equities.com, Fast Money Alerts, StockGuru, Stock Shock and Awe, Stock Twiter, Penny Dreamers, GrowthPennyStocks, Wallstreetbuzz, Cannabis Financial Network News, Jet-Life Penny Stocks, Penny Champions, Stocktwiter, Stocks To Watch, Penny Stock Rumble, Wall Street Equities Research, Equity Observer, Vantage Wire, FeedBlitz, Flagler Financial Group, Greenbackers, Pennybuster, TheMicrocapNews, OtcWizard, OTPicks, Stockgoodies, Pennystocktweeters.com, Wallstreetlivechat and Trade of the Week reported earlier on Enertopia Corp. (ENRT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.

Enertopia has been pursuing a Surface Exploration Program in Nevada since 2017. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.

The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.

Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.

Enertopia Corp. (ENRT), closed Wednesday’s trading session at $0.0744, up 20.1939%, on 806,438 volume. The average volume for the last 3 months is 552,044 and the stock's 52-week low/high is $0.0085/$0.289000004.

PharmaCyte Biotech, Inc. (PMCBD)

QualityStocks, OTCJournal, SmallCapNetwork, SmallCap Network, Shiznit Stocks, MarketBeat, Goldman Small Cap Research, Penny Stock Beats, PennyStockProphet, PennyStockRumors.net, PricelessPennyStocks, SmallCapVoice, Stock Market Media Group, Epic Stock Picks, Planet Penny Stocks, PennyStockLocks.com, Penny Stock General, StockOnion, StockRockandRoll, OTCtipReporter, Buzz Stocks, Cannabis Financial Network News, PennyStockScholar, Fast Money Alerts, Damn Good Penny Picks, Penny Stocks Profile, Otcstockexchange, Whisper from Wall Street, Penny Stock Craze, SecretStockPromo, Penny Pick Finders, Stock Preacher, InvestorSoup, Stock Shock and Awe, Actual Gains, Ascending Stocks, Penny Pick Insider, Penny Picks, Beacon Equity Research, OTCMagic, MicroCap, Daily Stock Motion, MyBestStockAlerts, Darth Trader, Jet-Life Penny Stocks, Equity Observer, InvestorPlace, HotStockProfits, Gryphon Digest, Orbit Stocks, Penny Stocks Finder, Wall Street Beauties, SuperStockTips, Value Penny Stocks, StockHideout, Promotion Stock Secrets, SMS Penny Picks, TopPennyStockMovers, ResearchOTC, PennyStock Tweets, WINNINGOTC, The Stock Psycho, Penny Stocks VIP, Stock Commander, EpicVIP Group, DSR News, The Bull Report, FatCat Stocks, Wall Street Mover, Wall Street Wolves, BUYINS.NET, Bull Trends, Between Traders, Wallstreet Profiler, AwesomePennyStocks, Wallstreetbuzz, WallstreetsHotteststocks, Wall Street Corner, OTC Journal, Penny Stock Newsletter and 1-2-3 Stock Alerts reported earlier on PharmaCyte Biotech, Inc. (PMCBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Company is also working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other kinds of solid cancerous tumors.  PharmaCyte’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form.

The capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. The live-cell encapsulation technology that the Company employs is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. It encapsulates living cells, not drugs. PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Australia and Europe.

Furthermore, the Company is developing treatments for cancer built upon chemical constituents of the cannabis  plant, called cannabinoids. PharmaCyte is studying ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects typically associated with cancer treatments.

PharmaCyte Biotech, Inc. (PMCBD), closed Wednesday’s trading session at $8.2776, up 27.5439%, on 27,148 volume. The average volume for the last 3 months is 6.567M and the stock's 52-week low/high is $N/A/$N/A.

BHPA, Inc. (BHPA)

We reported earlier on BHPA, Inc. (BHPA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BHPA is a client of Hestia Insight, Inc., Irvine, California. Esatblished in 2005, BHPA was previously known as Star Resorts Development, Inc. It changed its corporate name to BHPA, Inc. in June of 2019. The Company’s shares trade on the OTC Markets.

BHP Advance has a well-established worldwide partnership network with large-scale cryptocurrency mining farms such as RRMine. RRMine is a Global Computing Power Asset Management and Trading Platform of Hong Kong SuperB Grace Limited. It provides transparent and decentralized computing power management, settlement, and trading services to customers globally based on blockchain technology.

BHP Advance’s dedication is to providing a cloud mining solution capable of breaking new barriers in the cryptocurrency mining space, enabling crypto mining firms and enthusiasts to transcend the defining limitations of time, power, as well as the technology horizon.

BHPA previously announced that it and Q-Link Technology Ltd. agreed to build cooperation by signing a Memorandum of Understanding (MoU) on "The Intention to Acquire Q-Link by BHPA". The MoU signing took place at Hainan Eco-Software Park, High-tech Industry Demonstration Zone, Old Town, Chengmai County, Hainan Province, China, in mid-2020.

Q-link Technology is positioned as an international Computing Power Supplier. It provides computing power products and services to innovation companies. The core product of Q-Link is the hash power for BTC mining and One-stop IPFS system integration service. The MOU coverage is centered on the fields of, among others, the general content of the acquisition intention, the division of responsibilities and obligations of both parties, and the determination of exclusivity.

BHPA, Inc. (BHPA), closed Wednesday’s trading session at $1.9, up 46.1538%, on 5,398 volume. The average volume for the last 3 months is 2,819 and the stock's 52-week low/high is $0.475050002/$4.98999977.

CBD Life Sciences, Inc. (CBDL)

QualityStocks, StockRockandRoll, PennyStockLocks and Penny Stock 101 reported earlier on CBD Life Sciences, Inc. (CBDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.

LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”

CBD Life Sciences previously announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.

Recently, CBD Life Sciences announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.

CBD Life Sciences, Inc. (CBDL), closed Wednesday’s trading session at $0.0005, up 25%, on 1,223,400,703 volume. The average volume for the last 3 months is 472.558M and the stock's 52-week low/high is $0.000399999/$0.019799999.

North American Cannabis Holdings, Inc. (USMJ)

QualityStocks, Wall Street Corner, Promotion Stock Secrets, Pennybuster, StockHideout, SmallCapVoice, PennyStockRumors.net, PennyPickAlerts and Fortune Stock Alerts reported earlier on North American Cannabis Holdings, Inc. (USMJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Additionally, North American Cannabis operates a destination beverage company. It enables consumers to interface with staff to learn about the specific benefits of cannabis, and select healthy and refreshing cannabis infused beverages. These beverages include custom blended hemp infused coffee, cold pressed juices, and smoothies. Furthermore, the Company offers raw hemp seeds and other hemp infused foods.

North American Cannabis’ eCommerce site is www.USMJ.com. USMJ is a subsidiary company of North American Cannabis Holdings. USMJ partners with premier CBD producers. USMJ curates each product selection to work as promised and to ensure each item it sells is safe and effective.

North American Cannabis has a curated product line of legal cannabinoids and accessories. All of the Company’s products are lab-tested and contain no THC (tetrahydrocannabinol) through a carefully monitored extraction process.

North American Cannabis’ products are all natural, all safe, and all CBD (cannabidiol). The Company carries manifold CBD and CBG Smokable products in Pre Roll and Flower. It has greater than 150 CBD, Hemp, as well as Cannabis Essentials products available online.

Recently, North American Cannabis Holdings said that because of overwhelming demand, USMJ.com has streamlined its process to becoming a Vendor on USMJ.com. The USMJ.com Vendor program launched earlier but has been a slowly growing process.

Now, CBD/CBG Manufacturers and Vendors can apply and list their products on USMJ.com. Before now, it's been a series of emails. However, now there's a set discovery process to understand the products the Company is putting online and established marketing efforts to help businesses grow.

North American Cannabis Holdings, Inc. (USMJ), closed Wednesday’s trading session at $0.000935, up 16.875%, on 90,554,252 volume. The average volume for the last 3 months is 75.671M and the stock's 52-week low/high is $0.000099999/$0.008.

Cosmos Holdings, Inc. (COSM)

QualityStocks, TopPennyStockMovers, PoliticsAndMyPortfolio, OTC Markets Group and MarketBeat reported earlier on Cosmos Holdings, Inc. (COSM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Company distributes branded and generic medicines, over-the-counter (OTC) pharmaceuticals, food supplements, and medical via its trans-European network of more than 160 pharmaceutical wholesale clients and vendors and roughly 400 independent retail pharmacies that extends to 16 countries. These include Germany, the United Kingdom, France, Italy, Poland, the Netherlands, Greece, Hungary, Denmark, Ireland, and Croatia.

Regarding its new nutraceutical brand, Cosmos Holdings released the design and packaging of its first set of dietary supplements on April 19, 2018. These premium supplements feature a sleek design and packaging along with best in class formulation. The first lines of products include Herbal syrups with natural ingredients from Greece, Collagen 24k, Organic Aloe Vera, Hyaluronic, Male & Female Multivitamins, and more.

Specific areas of Company Management's focus include Branded Pharmaceuticals, Generic Pharmaceuticals, Health Products & Food Supplements, Research & Development, Acquisitions, Cannabis derived products, and Local & Direct to Pharmacy Wholesale.

Cosmos Holdings’ subsidiaries include Sky Pharm SA. Sky Pharm is based in Thessaloniki, Greece. Sky Pharm trades the excess amounts of approximately 500 medicines that can be exported within the European Union (EU) countries. Another subsidiary is Decahedron Ltd. Decahedron is a pharmaceutical wholesaler incorporated in the United Kingdom (UK) in August of 2011. A third subsidiary is Cosmofarm Pharmaceuticals. Cosmofarm is a fully licensed pharmaceutical wholesale company operating in the greater Athens area. Cosmos has entered the nutraceutical market with its own premium brand of food supplements - Sky Premium Life.

Recently, Cosmos Holdings entered into an exclusive distribution agreement with Mediprovita GbR (“Mediprovita”) to be the exclusive distributor in Germany and Austria of the Company’s Sky Premium Life, a proprietary, luxury and high-quality nutritional supplements' brand, with a complete range of vitamins, minerals, herbs and unique formulas.

Under the terms of the agreement, Mediprovita will employ its sales, marketing and e-commerce expertise to distribute Sky Premium Life products throughout Germany and Austria. In addition, Mediprovita will submit registration files on behalf of the Company within the territories. Cosmos expects to have approximately 25 Sky Premium Life SKUs launched in the next two months, and targets having all 65 SKUs listed on Amazon and eBay by year end.

Cosmos Holdings, Inc. (COSM), closed Wednesday’s trading session at $5, up 24.0695%, on 16,002 volume. The average volume for the last 3 months is 12,029 and the stock's 52-week low/high is $1.52999997/$9.00.

Argentina Lithium & Energy Corp. (PNXLF)

We reported earlier on Argentina Lithium & Energy Corp. (PNXLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Argentina Lithium & Energy has its Antofalla Project. This Project includes greater than14,000 hectares on the Salar de Antofalla in Salta Province, Argentina. This includes a 100 percent interest in roughly 9,000 hectares of mining claims in the north end of the Salar de Antofalla (Staked Properties) and an option agreement to earn a 100 percent interest in three additional properties totaling more than 5,300 hectares (Optioned Properties) positioned adjacent to the Staked Properties.

The Optioned Properties include two granted mine concessions and a third mine application. Terms of the option include cash payments totaling US$3,500,000 over 42 months but limited to only $500,000 in the first 18 months. Moreover, the option includes annual exploration expenditure commitments of $500,000 in year one, followed by $1.5M in year two, $2.0M in year 3, and $3.0M in year 4.

The Company has acquired a 100 percent interest in more than 25,500 hectares covering the Incahuasi Salar and basin in Catamarca province. This salar is within the “Lithium Triangle” of Argentina and Chile. It has characteristics prospective for lithium-rich brines. Initial sampling of near-surface brines returned up to 409mg/L lithium. Geophysical surveying indicates the potential for lithium-rich brines at depth.

Argentina Lithium & Energy is a member of the Grosso Group. The Grosso Group is a resource management group that has pioneered exploration in Argentina since 1993.

Argentina Lithium & Energy Corp. (PNXLF), closed Wednesday’s trading session at $0.1942, up 15.802%, on 205,920 volume. The average volume for the last 3 months is 67,059 and the stock's 52-week low/high is $0.039999999/$0.209800004.

The QualityStocks Company Corner

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, today announced a partnership with New to The Street TV in the production, broadcasting and distribution of commercials and digital billboards on “Hearing Loss Awareness.” According to the update, the agreement calls for 660 commercials, 110 per month for the next six months, and includes 156 digital billboards that will run three times per hour located throughout lower Manhattan, New York City, New York. Fox News, Bloomberg, Fox Business Network, CNN, CNBC, Newsmax TV, and MSNBC will televise the commercials over the next six months. To view the full press release, visit https://ibn.fm/wIGz9

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb).

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Wednesday’s trading session at $0.0127, off by 11.1888%, on 160,647,332 volume. The average volume for the last 3 months is 62.009M and the stock's 52-week low/high is $0.000000999/$0.097999997.

Recent News

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)

The QualityStocks Daily Newsletter would like to spotlight Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF).

Cancer metastasis is every patient and doctor’s nightmare when it comes to treating this deadly disease. Chemotherapy is usually the primary treatment option, with doctors following up with surgeries to remove any tumors. However, patients suffering from muscle-invasive bladder cancer have to make a life-altering decision to either undergo chemotherapy and have their bladder removed to reduce chances of the cancer recurring or take their chances with the cancer metastasizing and leave their bladder intact while undergoing chemotherapy. Additionally, companies such as Imagin Medical Inc. (CSE: IME) (OTCQB: IMEX) are focused on improving imaging during bladder cancer surgery, so patients who need to undergo surgical procedures to remove cancerous tissues can look forward to the use of these advanced systems to improve patient outcomes.

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures. Its initial focus is on bladder cancer.

The company’s first product is the i/Blue Imaging™ System, based on advanced optics and light sensors and employing patented ultrasensitive imaging technology. Imagin Medical believes the system can significantly improve surgeons’ ability to visualize and remove cancer cells.

Founded in 2016 and headquartered in Boston, Massachusetts, the company works to enhance its market potential by expanding its technology to multiple endoscopic indications, such as laparoscopic, colorectal and thoracic procedures, accommodating multiple contrast agents and illumination sources.

i/Blue Imaging™ System

The conventional method used for visualizing bladder cancer during surgery is an endoscopic procedure called a cystoscopy. This procedure uses white light to illuminate the bladder. White light has been used for decades and is the standard for more than 90% of the market. Blue light cystoscopy uses blue-filtered white light, which addresses the limitations of white light (such as detecting flat tumors and the fine edges that may result in cancerous cells being left behind during removal).

Blue light uses a contrast agent that causes cancer cells to fluoresce when illuminated. Surgeons are then able to more effectively visualize and resect the margins of bladder tumors to reduce the risk of recurrence. Notably, the use of the white light is still necessary during a blue-light procedure so that the surgeon can orient their position within the bladder.

Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopies. The i/Blue System combines the white and blue light with an FDA-approved imaging agent and simultaneously displays side-by-side images in real-time, without the necessity to switch back and forth between the two images.

The i/Blue Imaging System is unlike other methods available on the market today. It is external to the body and can attach to almost any endoscope model currently in use. This way, hospitals adopting Imagin Medical’s technology have the ability to use their current endoscopes without the need to purchase new equipment.

Bladder Cancer Prevalence

The company’s initial focus is bladder cancer, which is the sixth most prevalent form of cancer in the United States. In 2020, the number of new bladder cancer cases is expected to total 81,400, accounting for 4.5 percent of all new cancers diagnosed. The death rate in 2020 for cancer deaths associated with the bladder is forecast at 17,980, or 3% of all cancer-related deaths (https://ibn.fm/qLi3l).

Bladder cancer also has one of the highest recurrence rates among all forms of cancer, leaving about 600,000 people in fear that their cancer will return, according to Imagin Medical. The company is committed to addressing this issue, and i/Blue demonstrations have indicated that the use of both white and blue light can enhance accuracy of detection and removal of cancer cells, potentially lowering recurrence rates.

Based on Verified Market Research, the global bladder cancer research market was valued at $3.43 billion in 2018. It is estimated to grow with a CAGR of 4.03% through 2026, resulting in a projected $4.71 billion market (https://ibn.fm/rI7G6).

Management Team

E. James Hutchens is the Chief Executive Officer of Imagin Medical Inc. He is a proven entrepreneur with over 30 years of experience in management in the medical technology industry. Hutchens served as a managing partner with Origin Partners, a $55 million early-stage venture capital fund. He was also the founder and CEO of both Microsurge Inc. (a venture-backed minimally invasive surgical company) and Choice Therapeutics (an advanced wound-care company). He is a former member of the Board of Directors of the Brigham and Women’s and Faulkner hospitals. Hutchins holds a BS in Business Administration from Boston University.

John Vacha is the company’s Chief Financial Officer. He has 20 years of experience in the health care industry. Prior to Medtronic’s acquisition of Intact Medical Corp. in 2017, Vacha was the company’s President, CEO and a board member for seven years. He is a licensed CPA in Massachusetts. Vacha has an MBA and an MS in Accounting from Northeastern University in Boston. He is also a serving member of the Board of Directors at the South Boston Health Center. He currently has two patents in electrosurgical instrumentation.

Michael G. Vergano is the Director of Operations of Imagin Medical. He has been the President of The Harvest Group Inc. since 1998, where he has provided consultant services for startups and major corporations. Vergano has over 30 years of experience in the medical device industry. He has held management positions at Microsurge Inc., Ciba Corning Diagnostics and Boston Scientific Corp. He is currently the holder of 11 medical device patents and holds a BS in Mechanical Engineering from Tufts University.

Pam Papineau is the company’s Director of Regulatory Affairs. She has over 30 years of experience in quality and regulatory affairs with Boston Scientific, Baxter and Cogentix. She has served as a consultant on various devices including imaging, endoscopy, orthopedic, GI/GU and cardiovascular applications. Papineau has successfully prepared dozens of FDA pre-market and EU submissions to support CE marking of a broad spectrum of medical devices. She is an ASQ Certified Quality Engineer, a Certified Biomedical Auditor, a Certified Quality Auditor and an ISO 13485:2016 Lead Auditor, and she is certified by the Regulatory Affairs Professional Society – U.S., EU and Canada. Papineau works with the company’s legal counsel to prepare pre-submission meetings with the FDA and activities through the regulatory approval process.

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF), closed Wednesday’s trading session at $0.4192, up 4.8524%, on 1,585 volume. The average volume for the last 3 months is 6,787 and the stock's 52-week low/high is $0.200000002/$1.16999995.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a growth-stage company committed to providing commercially viable and sustainable energy solutions, has scheduled a webinar, during which CEO Ian Clifford will share a brief company overview as well as discuss recent announcements and upcoming milestones. The webinar is slated for July 15, 2021, and will begin at 11 a.m. EST. The update event will also set aside time for questions and answers. Specifically, the webinar will include the latest updates on FuelPositive’s exclusive carbon-free ammonia (“NH3”). NH3 is converting air, water and sustainable electricity into nonpolluting ammonia, fertilizer and fuel. In the announcement, the company noted the $20 billion existing annual market for chemical processing and the $56 billion existing annual market for fertilizer. The company also pointed to an emerging market in which NH3 could be used as an alternative to fossil fuels for a wide range of uses, including transportation, fuel cells, grid storage and powering remote communities. As part of its focus on NH3, FuelPositive is partnering with National Compressed Air Canada to build modular, easily transportable commercial prototype systems for the production of NH3. The company anticipates that demonstration prototypes will be available by the end of 2021, with pilot projects planned for Q1 2022. To register for the event, visit https://ibn.fm/ZAHpC. To view the full press release, visit https://ibn.fm/B5Kff 

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Wednesday’s trading session at $0.1919, up 5.4396%, on 830,121 volume. The average volume for the last 3 months is 747,980 and the stock's 52-week low/high is $0.0125/$0.326000005.

Recent News

RYAH Group Inc. (CSE: RYAH)

The QualityStocks Daily Newsletter would like to spotlight RYAH Group Inc. (CSE: RYAH).

Despite starting with relatively noble intentions, the drug war is considered an unmitigated failure by many. Not only did it fail to sufficiently curb drug use or suppress the criminal enterprises behind the drug trade, but it also ensured that certain communities were intensely policed and harshly sentenced for decades. Now that America’s state-legal cannabis sector is steadily growing, some policies from the drug war era that have endured may be creating “systemic barriers” for these communities. Hopefully the comments sent will result in the formulation of policies that make it easier for medical marijuana users to access devices such as the RYAH Smart Inhaler made by RYAH Group Inc. (CSE: RYAH), which helps cannabis users to determine the dosage of medical marijuana they consume.

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Product Portfolio

The company’s current portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component and the mobile application. The product line currently includes a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage.

RYAH Smart-Inhaler

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and presets for temperatures and dosages, all of which can be customized to individual needs and doctor recommendations, as well as a post-session review mechanism that allows the collection of session data and feedback for further efficacy analysis for customized dosing capabilities.

RYAH’s proprietary stainless-steel cartridges for the inhaler use QR technology that contains lab testing and grower information pertaining to the specific strain, thereby mitigating elicit product use and enabling completely transparent remote medicinal analytics, from seed to consumption.

In addition, the RYAH Cartridges provide a unique closed-loop recurring revenue opportunity for the company, as the RYAH Inhaler only works with this type of proprietary cartridges that licensed partners fill with medicine. The partners benefit from all the back-end data, providing them access to consumption habits, statistics and other data on patient preferences.

RYAH Smart-Patch

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and the heating element is completely IoT and controlled by RYAH’s proprietary smartphone applications, which allows scheduling and ‘boosting’ medicine release, on-demand.

RYAH Smart-Pen

The RYAH Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect’, enabling customized, wide-spectrum recommendation opportunities by licensed clinicians. The Smart-Pen will feature cartridges that contain CBD, THC and other isolates such as flavonoids or vitamins, or other solutions. There is a built-in mechanism designed to control usage based on recommended dosing schedules.

RYAH MD

RYAH MD serves as a remote and interactive patient-doctor collaboration and dosing administration platform. Doctors can remotely set dosage amounts for their patients, creating digital prescriptions for the RYAH IoT devices and tracking patient usage in real-time. RYAH MD offers features that include real-time monitoring, appointment booking, doctor-patient video calls and science-based strain recommendations, as well as promoting a better understanding of the effects and benefits of those recommendations among patients. Information is gathered from all of the RYAH devices.

PotBot App

The PotBot App is a medical cannabis education mobile application that leverages patented AI technology to capture structured and unstructured data to assist patients in learning about various treatments in plant-medicine based on their efficacy goals. The PotBot App is currently one of the top-rated medical cannabis educational mobile applications on the Apple App Store in the United States, with over 300,000 downloads.

Through the combination of peer-reviewed and empirical data, the PotBot App provides detailed information on the targeted and tested cannabinoid levels and associated strains from cannabis patients. The result is personalized and driven by data to inform patients of potential product matches associated with similar ailments and efficacy goals.

Market Outlook

RYAH holds a unique position in the $100.3 billion medical plant market, with the potential to capture and capitalize on growth opportunities made available by both the IoT and Data Intelligence sectors.

In 2018, the global IoT market was valued at $212.1 billion, and it is expected to grow exponentially to $1.3 trillion by 2026, registering a CAGR of 25.68%, according to Verified Market Research (https://ibn.fm/XtkPZ).

Management Team

Dr. Boris Goldstein, Ph.D., is the founder and Chairman of RYAH Group. He is a seasoned entrepreneur, investment banker and venture capitalist. He started his career as the founder of Software House HT, which grew into a worldwide corporation with over 40 offices in 17 countries. Since then, Goldstein has founded and served on the boards of directors and advisory boards for numerous companies in Silicon Valley and Silicon Alley. Goldstein brings experience in fundamental research, investment and technology, authoring multiple patents and books.

Gregory Wagner, MBA, is Chief Executive Officer and Director of RYAH Group. He has over 20 years of experience in global financial markets and entrepreneurship. Wagner has held executive roles in the United States and London. He has co-founded and built several startups from the ground up. His current licensures and degrees include FINRA Series 7, 63, 24 and 55, as well as an MBA from Fordham University. Wagner received a Certification in Innovation and Strategy from Harvard University.

RYAH Group Inc. (CSE: RYAH), closed Wednesday’s trading session at $0.075, up 7.14%, on 440,000 volume. The average volume for the last 3 months is 744,675 and the stock's 52-week low/high is $0.06/$0.20.

Recent News

Brain Scientific Inc. (OTCQB: BRSF)

The QualityStocks Daily Newsletter would like to spotlight Brain Scientific Inc. (OTCQB: BRSF).

  • BRSF is about to enter into a merger agreement to acquire Piezo Motion, a leading piezo motor technology developer
  • Piezo Motion's technology will be deployed to leverage massive amounts of data that can be analyzed by artificial intelligence to assist medical professionals and researchers in recommending adequate precision treatments
  • Merger expected to expand markets for both companies and their potential to deliver innovative technologies to high-growth segments

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has announced that it has entered into a definitive merger agreement to acquire Piezo Motion Corp., a leading innovator of high-precision piezoelectric motion technology (https://ibn.fm/WBhls). By combining aspects of physical and social sciences with machine learning, the two companies seek to better understand and address emerging commercial demands in the market. Once completed, the merger is expected to expand the market footprint both for Brain Scientific and Piezo Motion and their potential to deliver innovative technologies to high-growth markets.

Also today, BRSF announced it has partnered with Ehave Inc., a provider of digital therapeutics for the psychedelic and mental health sectors. The partnership is intended to change the fact that although there are currently 250 identified biochemical markers about a broad range of the body’s organic system and how they function, the approach to utilize them to improve diagnostic accuracy and patient outcomes remains challenging for psychiatric disorders. Additionally, experts caution that even though a potential breakthrough has been found pertaining to treating a range of mental illnesses, which could have profound implications for a space that has seen few pharmacological advancements over recent decades, more research is needed. To view the full article, visit: https://ibn.fm/vggxi

Brain Scientific Inc. (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. With a mission of modernizing brain diagnostics by employing cutting edge technologies to bridge the widening gap in access to quality care, the company offers two FDA-cleared products that provide next-generation solutions to the neurology market.

The company’s proprietary, clinical-grade neurological devices are supported by its intellectual property portfolio featuring patents in the United States, China and Europe.

Brain Scientific’s first commercialized devices, NeuroCap(TM) and NeuroEEG(TM), are designed to disrupt the current electroencephalogram (EEG) market by offering cost-effective and disposable substitutes to existing solutions, allowing medical professionals to collect diagnostic information quickly.

The company’s goal is to improve diagnostics by leveraging artificial intelligence and machine learning processes to analyze a database of brain readings as a method of detecting seizures and dementia. The company is also working to improve patients’ access to neurological care.

Headquartered in New York, Brain Scientific and its predecessor (and now wholly owned subsidiary, MemoryMD Inc.) was founded in 2015 and went public in 2018.

Brain Scientific’s first phase of development, from 2018 to 2019, saw the inception of portable, clinical-grade, easy-to-use neurological devices. The second phase, currently ongoing, aims to create cloud-based, secure infrastructure to transmit patient data between patients and their neurologists. The company’s third phase of development is scheduled for 2021-2022 and is expected to focus on the use of AI-assisted diagnostic analysis to increase the efficiency, consistency and accuracy of neurology specialists.

NeuroCap(TM) – Disposable EEG Headset

The NeuroCap is a disposable pre-gelled EEG headset featuring 22 electrodes and 19 active EEG channels, all adhering to the international 10-20 system. The NeuroCap was FDA-cleared in 2018. The headset can be used for recording EEGs in virtually any setting, including urban and rural emergency departments, neurology clinics, urgent care clinics, ICUs, nursing homes, assisted living facilities and remote clinical research labs.

Through a universal cable adapter, the NeuroCap is compatible with other EEG amplifiers. The cap also works in parallel with Brain Scientific’s NeuroEEG amplifier, initiating EEG studies in less than five minutes.

The company is currently seeking FDA approval for additional features for the NeuroCap, as the device has the potential to fill a gap in EEG testing availabilities during the current coronavirus pandemic: in October 2020, Brain Scientific filed an Emergency Use Authorization (EUA) application. The EUA is required for the rapid distribution of the NeuroCap device to emergency departments, intensive care units and other treatment centers to administer prescriptive EEGs safely on critically ill patients or those suspected of being diagnosed with COVID-19.

With more than 80 percent of hospitalized patients infected with COVID-19 displaying neurological symptoms, the NeuroCap could prove to be a valuable device by offering fast testing with limited contact between technicians and patients.

NeuroEEG(TM) – Miniature and Portable Wireless EEG Amplifier

The NeuroEEG is a compact, portable and affordable wireless EEG amplifier intended for prescription use. The 16-channel, FDA-cleared, clinical-grade device acquires, records, transmits and displays electrical brain activity for patients of all ages.

Both the NeuroCap and NeuroEEG are delivered by MemoryMD Inc., a wholly owned subsidiary of Brain Scientific.

Products in Active Development

Currently, Brain Scientific and MemoryMD are working on leveraging their existing products and drawing from ongoing research to develop and commercialize the next generation of solutions for the brain diagnostics market. The devices under development are being designed to address the following issues:

Routine EEG

  • NeuroCap-8 is an 8-channel EEG cap. The reduced number of electrodes is vital in emergency room situations, where the time it takes to set up the EEG is critical.

Pediatric EEG

  • NeuroCap Pediatric is positioned to become the first disposable and pre-gelled headset available for the pediatric market.

Long-Term Monitoring

  • NeuroCap LTM for adult and pediatric patients is a disposable cap designed to monitor rhythmic and periodic patterns for up to 72 hours, providing essential diagnostic capabilities.
  • NeuroEEG 24 Channel Amplifier is a portable and wireless amplifier with over 24 hours of battery life.

Artificial Intelligence

  • Brain E-Tattoo is a minimally invasive four-channel EEG electrode designed for long-term monitoring.
  • An AI database of brain biomarkers collects data on both normal and abnormal brain data to detect neurological diseases. The goal is for machine learning algorithms to enhance understanding of brain-behavior related to epilepsy, memory dementia and pre-Alzheimer’s diagnostics.

Telemedicine

Brain Scientific is expanding the vision for telemedicine in neurology. The company aims to address the current acute neurologist shortfall (20 states have less than 10 neurologists per 10,000 patients) through the use of teleneurology.

 

Partnership with Marketing Brainology

Brain Scientific has a longstanding partnership with Marketing Brainology, a neuromarketing firm using neuroscience approaches to understand consumer behavior. In 2019, Marketing Brainology conducted a study using NeuroCap and NeuroEEG to determine the most effective Super Bowl commercials.

“Thanks to Brain Scientific’s NeuroCap and NeuroEEG, we are able to better understand the art and science of the human decision-making process,” Michelle Adams, Ph.D, Founder of Marketing Brainology, stated in a news release.

In April 2020, Marketing Brainology again conducted a study leveraging Brain Scientific’s disposable EEG cap to determine how brains were reacting to COVID-19 messaging. Subjects were presented with multiple media impressions, and Marketing Brainology analyzed their responsive biomarkers. The results identified the most effective messaging for engaging with an audience during a crisis.

Market Outlook

The current global market for EEG devices is estimated at $956.1 million. It is expected to rise with a CAGR of 8.7% from 2019 to 2026, reaching $1.6 billion in value by 2026, according to Grandview Research.

In total, there are approximately 6,150 hospitals in the U.S., according to the American Hospital Association. Critically, though, just 254 of those hospitals are certified Level 4 Epilepsy centers with 24/7 EEG coverage. Since very few non-Level 4 centers have extensive EEG tech coverage, this creates a significant opportunity for Brain Scientific to bridge the gap by providing over 5,900 hospitals with lower cost amplifiers and disposable EEG caps.

The company also see opportunities to work with other businesses, such as EEG manufacturers hoping to package Brain Scientific’s solutions with their products, which could greatly expand Brain Scientific’s addressable target market.

Management Team

Dr. Baruch “Boris” Goldstein, Ph.D., is co-founder and Chairman of Brain Scientific. He is a seasoned executive with a proven talent for aligning global business strategies with established and emerging management teams. Goldstein’s growth-focused leadership style has helped him raise over $750 million in venture capital for the development of innovative companies and startups in diverse industries, including financial services, biomedicine, alternate energy and new materials, as well as groundbreaking work in artificial intelligence. His recent achievements include important advancements in neurology and unlocking the potential of AI correlations and machine learning applied to life sciences and medical research. He built a suite of first-to-market companies as a technology-oriented leader, including Ryah Medtech, Brain Scientific, GrapheneCA, E-Forex and Intelligent Video Systems. He also co-founded BrainRX, a company specializing in pre-Alzheimer’s diagnostics.

Dr. Nikolay Kukekov, Ph.D., is a Director of Brain Scientific and a partner at HRA Capital. Before joining HRA Capital, Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research. His scientific background includes a bachelor’s degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. He earned his Ph.D. in neuroscience from Columbia University – College of Physicians and Surgeons in New York.

Stuart Bernstein is the company’s Vice President of Marketing. He was recently named to the role after spending the first part of his professional career in senior technical management roles with Fortune 500 companies such as NCR (NYSE: NCR), IBM (NYSE: IBM) and Control Data Corp. He was the CEO of BioSignal, an EEG medical device company. He is also a co-founder of several software engineering and telemedicine firms. One of them, Brain Saving Technology, is now Specialist on Call (SOC Telemed) – a leading telemedicine company that powers over 850 facilities for teleneurology, telepsychiatry and critical care telemedicine with over 200 physicians.

Brain Scientific Inc. (OTCQB: BRSF), closed Wednesday’s trading session at $0.38, even for the day. The average volume for the last 3 months is 29,745 and the stock's 52-week low/high is $0.116099998/$2.20000004.

Recent News

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF)

The QualityStocks Daily Newsletter would like to spotlight First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF).

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, has released results of drill hole LC21-003 at its Augustus Lithium Property in Quebec, Canada. The announcement stated that the drill hole intersected a six-meter-wide zone with 0.62% lithium oxide (“Li2O”) at 45 meters in depth; the hole included a two meter-wide wide intersection with 1.35% Li2O at 48 meters depth. In addition, a second two-meter-wide pegmatite intersection assayed 0.63% Li2O at 73 meter depth. First Energy noted that its  trenching and sampling program is still underway. To view the full press release, visit https://ibn.fm/p8MG8

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) is a publicly traded Canadian mineral exploration company. Its primary focus is on developing a multi-commodity mineral property portfolio by identifying, acquiring and exploring North American mineral prospects in the precious metal, base metal and industrial metals sectors.

Headquartered in Vancouver, the company (formerly known as “Agave Silver”) was first incorporated on October 12, 1966.

Core Properties – Augustus Lithium and Titan Gold

Located in Landrienne & Lacorne-Townships, Quebec, Canada, in an active lithium exploration/mining area, the Augustus Lithium Property and surrounding claims total 14,367.71 hectares . It is equipped with excellent infrastructure support, including a road network, railway, electricity, water and trained manpower available locally.

Other highlights of the Augustus Lithium Property include:

  • Geologically similar to Sayona Mining’s Authier Lithium project and Mine Quebec Lithium project located 6-12 km away.
  • Documented historical drilling over 10,000m in 62 drill holes, worth over $2 million in present day exploration expenditures.
  • Two prominent lithium and one silver prospects located on the property.
  • A potential high grade lithium resource target of 4 million tonnes at 1% lithium oxide (Li2O).
  • Potential for large volume low grade bulk tonnage near surface.
  • Two phase exploration work program includes: data compilation, geological mapping, trenching and sampling in Phase 1 (estimated cost $191,418) and diamond drilling, metallurgical testing and resource estimation in Phase 2 (estimated cost $1,166,963).

The Titan Gold Property is located in the Detour-Fenlon Greenstone Belt of east-central Quebec and is comprised of 80 mining claims totaling 4,334 hectares.

Other highlights of the Titan Gold Property include:

  • The Detour-Fenlon Greenstone Belt is host to the Detour Mine containing 20 million ounces of gold. The Fenlon Project of Wallbridge Mining has also reported strong high-grade gold intercepts and a successful high-grade (18.49 g/t Au) bulk sample.
  • Hosted within a structurally active geological environment with several northwest trending deformation zones which are splays off the Sunday Lake Deformation Zone – all key ingredients to the gold mineralization in the area.
  • The property has seen little historical exploration yet sits within what is becoming a prolific recognized gold camp.

Non-Core Properties – Kokanee Creek Gold and Scramble Mine Properties

The Kokanee Creek Gold Property consists of three mineral claims covering approximately 1,590.29 hectares in the Nelson Mining Division in British Columbia.

Other highlights of the Kokanee Creek Gold Property include:

  • Gold mineralization indicated in surface samples from historical work since 1979.
  • Subsurface gold mineralization discovered in drill holes.
  • Continuity of mineralized zones indicated through geological mapping, geochemical and geophysical survey.
  • Past producing mines in the vicinity, including the Molly Gibson and the Alpine deposits.
  • Historical production reported for the Molly Gibson Mine from 1909-1940 was at an average grade of 36.1 g/t Au and 15.3 g/t silver, with recent exploration returning samples running up to 270 g/t Au.
  • Revived exploration on the Alpine deposit area has reported a 2018 inferred resource of 142,000 oz at 16.52 g/t Au using a cut-off grade of 5.0 g/t.

First Energy Metals also holds an option to acquire a 100% interest in the Scramble Mine Gold property, located approximately 8 km east of the town of Kenora in Northwestern Ontario. The mine was discovered in 1894 but remained essentially dormant until 1984, when Boise Cascade Canada Ltd. commenced an evaluation of the property. Since 1984, approximately 5,200 meters of diamond drilling, 250 meters of surface stripping with sampling and 450 meters of underground development have taken place at the property.

Other highlights of the Scramble Mine Property uncovered as part of the company’s 2020 prospecting and sampling programs include:

  • Average value of gold in surface samples is 29.34 grams per tonne (1.03 ounces per tonne).
  • Gold assays ranged from 5.03 grams per tonne (0.18 oz/t) to 82.30 grams per tonne (2.90 oz/t), with two samples assayed over 2 oz/t.
  • All samples assayed over 5 grams per tonne gold.

Market Outlook

The global precious metals market was valued at $193.3 billion in 2020 and is expected to grow at a CAGR of 9%, resulting in a market valuation of $362.1 billion by 2027 (https://ibn.fm/WvN9Z).

The global lithium metal market was valued at $534.6 million in 2020. Through 2027, it is expected to grow at a CAGR of 9.6%, resulting in a forecast valuation of $926.6 million (https://ibn.fm/xBXcx).

First Energy Metals is well positioned to leverage growth opportunities in these expanding sectors through exploration of both its core and non-core properties.

Management Team

Gurminder Sangha is the Chief Executive Officer and Director of First Energy Metals Ltd. He is experienced in the financial industry, focusing on providing advisory-level services to privately and publicly traded companies. Mr. Sangha brings over 18 years of diverse experience related to financial management, business leadership and corporate strategy to his role with First Energy Metals. During his tenure as a board member for various publicly traded companies, he has led initiatives related to corporate finance, business development and corporate governance. Mr. Sangha has an MBA from both Queens University and Cornell University.

Jurgen Wolf is the Chief Financial Officer and Corporate Secretary for First Energy Metals Ltd. He has been involved in the oil and gas industries for over 15 years, assisting public companies with administration and investor relations. Mr. Wolf was educated in Germany and immigrated to Canada in 1953. From 1958 to 1982, he owned and operated pre-cast concrete factories in Calgary and Vancouver. From 1982 to 2002, Mr. Wolf owned and operated J.A. Wolf Projects Ltd., a commercial construction company. He is the previous President and Director of the former US Oil and Gas Resources Inc., which amalgamated to form Petrichor Energy Inc. in 2005. Mr. Wolf retains director roles with several public companies.

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF), closed Wednesday’s trading session at $0.1667, even for the day. The average volume for the last 3 months is 11,366 and the stock's 52-week low/high is $0.086999997/$0.45719999.

Recent News

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF)

The QualityStocks Daily Newsletter would like to spotlight Pac Roots Cannabis Corp. (PACR).

  • Market for legal cannabis continues to mature, British Columbia government to allow cannabis home delivery starting July 15, 2021
  • PACR produces premium top-quality strains cultivated using genetics-first approach, catalog features 350 tested cultivars and 50 super-elite strains prized for unique cannabinoid profiles
  • PACR leverages branding power through recent acquisition of legendary Lords of Grasstown brand inspired by Pacific Northwest motorcycle culture

As the market for cannabis continues to shift towards legal avenues for product procurement, Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canada-based cannabis company, continues to position itself for an increased market share through a genetics-focused approach that produces the highest-quality strains available on the global market.

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach.

The company is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top quality products. Pac Roots has announced multiple promising initiatives in recent months since it commenced trading on the Canadian Securities Exchange on May 4, 2020. The company has a partnership with Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as a JV partnership with Rock Creek Farms and Speakeasy Cannabis Club leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within its first year of trading.

Furthermore, the company recently completed an agreement to acquire all issued and outstanding shares of a firm holding 250 acres of land in the famed Fraser Valley Region of British Columbia.

Pac Roots is also in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through an elite line of 350+ unique, high-grade cultivars. Pac Roots expects to receive a cultivation license for the facility in the fourth quarter of 2020.

High-End Selectively Bred Genetics

Pac Roots focuses on high-end genetics in order to maximize the quality of its products while maintaining high yields and profit margins.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for generations. Historically, this practice was restricted to underground cannabis producers developing their own strains.

The legalization of the cannabis industry has given producers access to thousands of cultivars located throughout the world while accelerating research into cannabis genetics. By carefully selecting strains, growers can control the size, color, smell, density and texture of cannabis buds, thereby creating distinctive, premium cannabis products.

Plants are bred to thrive in specific growing environments. This maximizes the yield of high-quality, resilient cannabis. Medical cannabis strains can also be tailored for specific medicinal purposes.

A strategic partnership with Phenome One, a plant breeding management and analytics firm, gives Pac Roots access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains featuring a variety of beneficial characteristics.

The company’s 350+ licensed live cultivars and over 1,800 seed varieties are the result of a meticulous gene selection process, through which as many as 600 individual plants may be grown to produce a single strain. Selecting optimized genetics in this way provides benefits beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, Pac Roots is able to grow more cannabis per grow light.

Breeding plants to be more resilient also reduces the cost and labor required. These factors, combined with the premium price point associated with top-quality cannabis, have the potential to improve Pac Roots’ overall profit margin.

Partnership with Phenome One

Pac Roots has secured its cultivars through a strategic licensing agreement with Phenome One. Under the agreement, Pac Roots has unlimited access to Phenome One’s live genetic library, including any of Phenome One’s cultivars and its growing, breeding and cloning IP.

Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on over 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested, with data going back more than 30 years.

Using Phenome One’s data, Pac Roots plans to grow a variety of cannabis plants optimized for certain traits. One such trait will be plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome One’s library could enable Pac Roots to produce plants that are bred to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

Joint Venture with Rock Creek Farms of British Columbia

Pac Roots recently entered a definitive investment agreement with Rock Creek Farms, a reputable agricultural enterprise, for a 100-acre commercial hemp operation in Rock Creek, British Columbia. The growing space is located in the highly lucrative farming area known as the ‘Golden Mile’ in the South Okanagan Valley of British Columbia. (http://nnw.fm/Gbf9I).

Under the agreement, the two companies have formed an outdoor premium hemp joint venture company to which Pac Roots is providing an aggregate of $450,000 in capital and Rock Creek Farms is contributing two commercial leases for 100+ acres of growing space, along with cultivation licenses, agricultural infrastructure and equipment, consulting services, intellectual property relating to hemp operations and proprietary biomass storage methods. Pac Roots holds a 60 percent interest in the project.

About 127,500 premium hemp CBD seedlings were planted across 100 acres as of early July 2020. The joint venture is planting a premium grade CBD hemp variety utilizing the rich native soil and both traditional and custom farming techniques.

“Our operational partners at Rock Creek Farms bring decades of generational farming expertise in one of Canada’s pre-eminent growing regions,” Pac Roots President and CEO Patrick Elliott said in a news release detailing the venture. “It will be an exciting outdoor growing season for the joint venture as we anticipate a successful harvest in the fall.”

Infinite Development Possibilities at Fraser Valley Property in British Columbia

In September 2020, the company announced the closing of a share purchase agreement with 1088070 BC. LTD. (“1088”) and its shareholders for the acquisition of all issued and outstanding shares of 1088 (https://nnw.fm/9gXHk). Through this agreement, Pac Roots gained ownership and control of 250 acres of land spread over nine parcels in the Fraser Valley Regional District.

The Fraser Valley Regional District is one of the most productive and intensively farmed areas of Canada, offering access to high-quality soil, favorable climate, water and a local market of 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

According to Elliott, the addition of such a significant package of land is a major step for Pac Roots.

“The addition of such a substantial package of land to our portfolio is a major step for Pac Roots. We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre. This land has no zoning restrictions and is not situated within the Agricultural land reserve, which provides for infinite development possibilities,” Elliott added in the September 2020 news release.

Board of Directors member Chad Clelland also welcomed the acquisition, adding that between Fraser Valley and Rock Creek – both of them among the most productive agricultural regions in Canada – Pac Roots is very well positioned for production and the future development of its hemp and cannabis infrastructure.

The RAD Americas Genetic Program – Research and Development in Americas Genetic Program

Pac Roots intends to deploy a global R&D program focused on rigorously testing elite strains in various rich agricultural regions throughout the Americas, with a goal of mass selection to achieve the utmost environmental resilience while achieving notable quality and yields. From seed to software, collection data, proprietary techniques and custom nutrient formulas, Pac Roots and Phenome will provide the specific knowledge to cultivators in different climates in order to achieve optimal yields for THC, CBD, CBG and other unique cannabinoids. R&D from global testing programs situated throughout the Americas will allow the partnership to deploy and stress test a range of suitable cultivars in the world’s lowest cost outdoor growing regions.

The company expects an industry shift in 2020 from the COVID-19 global pandemic. The ‘new normal’ will bring more focus on efficiencies and optimal yields to deliver a cost effective, high quality product to the end user. There has been much to be learnt from the inefficiencies in the cannabis industry in recent years, which have been detrimental to the credibility of the sector. Pac Roots is well positioned to enter the scene and take advantage of the deficiencies, reinforcing the notion that genetics and flawless growing techniques are paramount to success. Genetics and systems innovation may be the most overlooked components when comparing cannabis to other established agricultural crops. Pac Roots plans to invest into cannabis R&D to ensure a solid foundation is built that will be used by cannabis farmers worldwide.

Through its RAD Americas Development and Innovation, Pac Roots is focused on:

  • Deploying one of the largest live genetic libraries in Canada, diversified for high yield output and unique climates
  • Continued stress testing for indoor, high yield, THC and medicinal genetics
  • Continued stress testing for outdoor, high yield, THC and medicinal genetics
  • Exotic, genetic cloning for the luxury, high margin, cannabis flower market
  • Psychoactive/medicinal ratio testing for effect and
  • Unique Cannabinoid and terpene elevation and isolation.

Through its RAD Americas Field Testing System, the company is focused on:

  • Global testing in different microclimates to assess genetic and complete systems for optimal yields
  • Data collection, testing and optimization to prove process for commercial implementation and
  • High quality yield testing for THC, CBD, CBG and other unique medicinal cannabinoids.

Lake Country Cultivation Facility near Kelowna, British Columbia

Pac Roots is in the process of completing its 20,000 square foot cultivation facility in Lake Country, British Columbia. The facility is expected to feature approximately 7,600 square feet of cultivation space that will enable the company to cycle through its line of high-grade cultivars. Pac Roots plans to submit a video evidence package of the facility build under Health Canada’s Cannabis Tracking and Licensing System, and the company expects to acquire its cultivation license in the fourth quarter of 2020.

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan region is attracting attention from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history has left it rich with experienced agricultural workers and an abundance of Agricultural Land Reserve (ALR) property.

Management Team

Patrick Elliott, MSC, MBA, President and CEO of Pac Roots Cannabis, is also the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company, as well as Phenome One Corp., a full-service cannabis farming company focused on elite strain selective breeding. Elliott brings over 15 years of corporate finance, mineral exploration and financial markets experience to the Pac Roots team. He is a graduate of the University of Western Ontario in geology and holds an MSc. in mineral economics and an MBA from Curtin University of Technology in Perth, Australia. Elliott specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Elliott has a wealth of contacts in the financial sector.

Marc Geen, Founder and Strategic Operations Advisor, is a fourth-generation British Columbia farmer who has been active in the legal medical marijuana industry for more than 10 years – consulting on, complying with, and participating in the MMAR, MMPR and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd., Geen spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd., one of North America’s largest ginseng producers. With the experience gleaned from a long career in large scale commercial farming, Geen has been able to apply many cost-effective farming practices to the outdoor, indoor and greenhouse cultivation of cannabis. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill, Director, has a strong background in both commercial and residential real estate and has played a major role in many development projects. McGill, through McGill Realty, has established a tremendous commercial and residential outfit servicing British Columbia’s Fraser Valley and the lower mainland. McGill is skilled at crafting strategic financing options for corporations and has a substantial network of retail and institutional clients.

Chad Clelland, Director, has experience in the sector dating back to 2009, when he purchased Medicalmarijuana.ca, which became an information portal for thousands of patients, doctors and growers. Through this company, he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Clelland co-founded Greenleaf Medical Clinic, which is now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.

Josh Bromley, Senior Cultivation Strategist, is a second-generation farmer with over two decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Bromley has developed proprietary farming systems, as well as low cost/high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality.

Pac Roots Cannabis Corp. (PACRF), closed Wednesday’s trading session at $0.10845, even for the day. The average volume for the last 3 months is 962 and the stock's 52-week low/high is $0.009999999/$0.204500004.

Recent News

Save Foods Inc. (NASDAQ: SVFD)

The QualityStocks Daily Newsletter would like to spotlight Save Foods Inc. (NASDAQ: SVFD).

Save Foods (NASDAQ: SVFD) is an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables. The company today announced that its wholly owned Israeli subsidiary, Save Foods Ltd., was granted a patent by the Israeli Patent Office for its new generation of natural disinfecting composition and method to protect edible matter from decay. According to the update, this is Save Foods’ fourth issued patent in Israel and seventh globally. To view the full press release, visit https://ibn.fm/CVJ1D

Save Foods Inc. (NASDAQ: SVFD) is an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables. The company is focused on addressing two of the most significant challenges faced by the industry: (1) food waste and loss, and (2) food safety.

Fungi like mold and yeast, as well as foodborne pathogens, are typically responsible for fresh produce spoilage and foodborne illness. Save Foods’ integrated solutions improve safety, freshness and quality every step of the way, from field to fork. The company’s natural products control human and plant pathogens, allowing growers, packers and food retailers to reduce waste and boost revenues. More food ends up on consumers’ plates, and less ends up in landfills.

Save Foods’ products use all-natural ingredients to protect fresh produce from microbial spoilage and pathogens with zero toxicity. The company’s treatments leave no harmful residues on produce or in the environment and maintain product freshness over time. Fresh produce treated with Save Foods’ products can already be found in supermarket chains across the U.S. and Europe. Those chains have reported that the company’s products are reducing fruit spoilage by 50% on average at the retail level. With no need for additional steps in the treatment process nor special equipment, Save Foods’ products are easy to implement and come in versatile applications suitable for the different stakeholders along the food supply chain.

Initial applications for the company’s offerings include post-harvest treatments in fruit and vegetable packing houses that process citrus, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of chemicals and their residues, Save Foods’ products not only prolong shelf life; they also ensure safe, natural and healthy food. Save Foods has the first green products that could realistically replace the different chemicals used today in food treatment while controlling waste and food safety.

Products & Technology

  • SavePROTECT or PeroStar, a processing aid added to fruit and vegetable wash water and used in post-harvest treatment;
  • SF3HS and SF3H, post-harvest treartment solutions to control both plant and foodborne pathogens;
  • SpuDefender, for controlling post-harvest potato sprouts; and
  • FreshPROTECT, for controlling spoilage microorganisms on post-harvest citrus.

Save Foods’ products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of sanitizers and fungicides at low concentrations in a non-organic setting. The combination eliminates fungicide residues or reduces them to levels below the established Maximum Residue Levels (MRLs). The company’s fruit and vegetable wash is odorless and does not irritate human eyes, skin or airways. Save Foods’ blend does not leave any residues of toxicological concern on the treated surface of produce, and all its ingredients are classified by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS). There are 7 patent families related to Save Foods’ technology.

Applications

The company’s products have been commercially validated on citrus, mangos, avocados, pears, bell peppers, microgreens and various fresh cut vegetables. Save Foods is in the validation process for bananas, apples, figs, berries, lettuce, papayas and more. The company is also validating the efficacy of its products for pre-harvest treatment, starting with citrus trees.

Market Outlook

The world population is expected to grow to almost 10 billion by 2050, boosting current agricultural demand by some 50%. Providing healthy and safe food for the world’s population is one of the biggest challenges of the 21st century.

Globally, around 664 million tons of fresh fruits and vegetables are lost every year from field to fork, wasted by spoilage, and almost one in 10 people globally falls ill every year from eating contaminated food, with an estimated resulting cost around $90 billion.

Disposing of all that wasted food requires additional expense and harms the environment with resulting greenhouse gas emissions. The post-harvest food treatment market was valued at $1.5 billion in 2019 and is expected to grow to $2.3 billion by 2026, achieving a CAGR of 6.5%.

Management Team

David Palach is CEO of Save Foods. He spent over a decade with Intel Israel, where his last position was Manager of Business Development for Israel and Europe. Prior to that, he served as a controller of two of Intel’s largest factories in Israel, where he supervised a budget of over $1 billion. He also served as the CEO of B-Pure Corporation Ltd., a management and maintenance company involved in protecting and improving the environment. During his tenure, he helped turn around several struggling subsidiaries and made them profitable.

Vered Raz Avayo is the company’s CFO. Before joining SaveFoods in 2018, she spent more than 10 years as CFO at LGC, the Leviev Group of Companies. She has operated her own financial and business consultancy and has served as a director for a number of public companies in Israel.

Dan Sztybel is CEO of SaveFoods Ltd., the Israeli subsidiary of Save Foods Inc. He previously led the Life Sciences Advisory at EY Israel and early on recognized the potential of Israel as a center of innovation in the digital health space. He has been an adviser on digital health strategy to large pharmaceutical companies and is a cofounder of MyndYou, a digital health start-up focusing on cognitive impairment. He is also a co-founder of the DigitalHealth.il conference, the largest digital health conference in Israel.

Dr. Neta Matis is Vice President of R&D at Save Foods Ltd the Israeli subsidiary of Save Foods Inc . She holds a Ph.D. in organic chemistry and an MBA from Tel Aviv University. Prior to joining Save Foods in 2019, she held multiple research chemist and product development roles at Verdia Inc. and its parent company, Helsinki-based Stora Enso Oyj.

Nimrod Ben Yehuda is the founder and CTO of Save Foods Ltd. He was previously the CEO/CTO of Swissteril Water Purifications Ltd. He has also been CEO at Nir Ecology Ltd., and was Joint-CEO at NitroJet Ltd.

Dr. Art Dawson is the U.S. Business Manager for SaveFoods Inc. He has been president of The Dawson Company, which focuses on creating sales opportunities for new agricultural technologies, previously Dr. Dawson held senior industry positions like General Manager Worldwide of the Decco , the Post Harvest Division for Elf Atochem. He holds a Ph.D. in Plant Physiology from UC Riverside and is licensed in California as an agricultural Pest Control Advisor.

Save Foods Inc. (SVFD), closed Wednesday’s trading session at $9.1706, off by 1.1256%, on 2,447 volume. The average volume for the last 3 months is 12,696 and the stock's 52-week low/high is $1.75/$30.1000003.

Recent News

Ideanomics Inc. (NASDAQ: IDEX)

The QualityStocks Daily Newsletter would like to spotlight Ideanomics Inc. (NASDAQ: IDEX).

Electric vehicles (“EVs”) are poised to replace conventional gas-powered vehicles gradually over the next couple of decades. By discarding the century-old internal combustion engine in exchange for lithium-ion batteries and electric motors, several countries, including the United States, hope to cut down on their carbon emissions. However, a recent report commissioned by the Pentagon says that zero-emission electric cars may not be feasible for the U.S. Army, potentially locking the industry out of a market that spends big on new technologies. Titled “Powering the US Army of the Future,” the report by the National Academies of Sciences, Engineering, and Medicine analyzed the future energy requirements of manned and unmanned vehicles and dismounted soldiers on multi-domain battlefields through 2035. Specifically, it centered on the energy needs of an armored brigade combat team that uses a combination of light vehicles, tactical vehicles and distributed soldiers. The authors of the report recommended that the army diversify the fuels it uses to run its ground vehicles but warned that battery electric vehicles and electricity are not practical. While some resistance is to be expected from institutions that have relied on fossil fuel since their creation, the push to vehicular electrification being championed by entities such as Ideanomics Inc. (NASDAQ: IDEX) is likely to gain momentum as time goes by, and institutions such as the Army may have no option but to adapt.

Ideanomics Inc. (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. Ideanomics is currently divided into two divisions – mobility and capital. These divisions provide shareholders with access to disruptive and high-growth opportunities.

The company expects 2021 to be another growth year after it raised approximately $400 million over the past six months. This funding has already been put to good use with acquisitions of Wireless Advanced Vehicle Electrification (WAVE) and Timios. With roughly $200 million still on the balance sheet, Ideanomics continues to look for new investments and acquisitions in revenue-based opportunities focused on EV and fintech businesses.

Founded in 2004, Ideanomics is headquartered in New York, New York, with additional offices in Hangzhou, Beijing and Qingdao, China. Its current operations span the United States, China, Ukraine and Malaysia.

Ideanomics Mobility

Ideanomics Mobility is focused on the EV market. The global commercial EV market was valued at $34.7 billion in 2018 and is expected to grow at a CAGR of 39.9% through 2022 to reach a total of $132.73 billion (https://ibn.fm/pPrf4). According to a survey by Grand View Research, the global EV charging infrastructure market is also expected to grow and reach $144.97 billion in 2028, expanding at a CAGR of 33.4% from 2021 to 2028.

This growth is expected to be driven by increased support of electric vehicles from the public, as well as the current U.S. administration, which has a goal of achieving a 100% clean-energy economy.

The Ideanomics Mobility unit consists of five companies:

  • Mobile Energy Global (MEG) – Wholly owned China-based service provider of the Sales-to-Finance-to-Charging (S2F2C) business model to assist commercial fleet operators on EV enablement. Recent sales include 2,000 units of D1, BYD’s custom electric ride-hailing vehicle.
  • Medici Motor Works – Wholly owned North America division. MMW will develop zero-emissions specialty vehicles, trucks, buses and vans for the North American market.
  • Wireless Advanced Vehicle Electrification (WAVE) – Wholly owned Utah-based commercial EV charging technology company with a specialized offering of in-ground wireless charging for commercial vehicles. WAVE’s chargers power the Antelope Valley Transportation Authority, the largest municipal EV bus system in the country. Its revenue for 2020 exceeded $7 million, and it boasts a robust pipeline for 2021 and beyond.
  • Treeletrik – Majority investment in Malaysian-based OEM will service a high-demand market – electric delivery mopeds. Treeletrik has obtained certifications in Thailand and Indonesia, with orders secured for 2021. Its North American marketing program is expected to commence in 2021. As a part of the ESG initiative, one tree will be planted for every unit sold.
  • Solectrac – Minority investment in California-based electric tractor company. Solectrac manufactures 100% electric tractors to benefit farmers, crops and the planet at a time when the agriculture market remains virtually unaddressed by EV solutions.
  • Silk EV – Minority investment in hyper car and performance car design company, which provides access to the high-end battery and charging technology development ecosystem.

Ideanomics is generating EV revenue from its Sales to Financing to Charging (S2F2C) business model, which features three operating areas:

  1. Vehicle and Battery Sales: Medici, Treeletrik and Solectrac cover three key market segments
  2. Financing, Leasing and Insurance: Offering financial services to fleet customers, commission delivery and origination fee-based revenue
  3. Charging and Energy Services: Offering charging as a service, battery swap programs and WAVE wireless charging products

Ideanomics Capital

Ideanomics Capital is focused on providing disruptive fintech solutions across the entire board of financial services, ranging from financial markets to digital securities and assets to mortgages and more. More mainstream institutions and a growing number of companies have increased their digital securities services, along with institutional investments boosting bitcoin and the emergence of favorable regulatory developments, creating ample opportunities for widespread adoption of financial technologies.

Additionally, the U.S. real estate industry is ripe for technologization, as it currently is fragmented, antiquated, opaque and largely untouched by tech innovation. However, the expanding market, with U.S. home sales expected to grow 21.9% in 2021, and the increased digitization of all business spaces are expected to promote a digital-first experience as the new industry standard this year and beyond (https://ibn.fm/DwsUv).

The Ideanomics Capital unit consists of five companies:

  • Timios – Wholly owned subsidiary bringing real estate into the 21st century by providing value-add, fee-based services addressing the title and closing process of home buying and mortgage transactions. Timios works to create transparency and efficiency within the market. Timios ended 2020 as a cash flow and EBITDA positive business.
  • The Delaware Board of Trade (DBOT) – Wholly owned FINRA-regulated ATS and broker dealer based in Delaware.
  • Liquefy – Minority investment bringing innovation to investment in real assets with blockchain technology by increasing efficiency in fractional ownership, lowering entry to investment barriers and unlocking liquidity in assets that were previously illiquid.
  • Technology Metals Market (TM2) – Minority investment in UK company delivering a direct investment and trading market for technology metals with a newly accessible technology metals asset class for inventory diversification. The traded metals are 100% backed by physical metals.
  • Intelligenta – Investment providing AI and machine learning solutions for financial institutions and regulators.

Management Team

Alf Poor is Ideanomics’ Chief Executive Officer. He is a client-focused and profit-driven executive who has a track record of success in rapidly growing technology companies and large, multi-national organizations. Mr. Poor’s expertise includes business planning, financing and creating and implementing corporate governance policies, as well as handling management across organizations. His specialization is working with cross-border and multi-national startups. Before taking the CEO role at Ideanomics, he was the CEO for Global Data Sentinel.

Conor McCarthy is the company’s Chief Financial Officer. He is a strategic and operationally oriented management-level professional. His extensive international experience is within the fintech, data science and advertising technology sectors. Mr. McCarthy has experience with public companies, PE, and VC-backed firms. His specializations are financial and management reporting, planning and analysis, financial modelling, performance metrics, KPIs, venture borrowing, Series A equity funding, ERP system implementation, international business operations, and acquisition due diligence and integration. Before joining Ideanomics, Mr. McCarthy most recently held a CFO position at OS33. Prior to that, he was CFO for Intent Media Inc.

Kate Lam is the company’s Managing Director of Financial Products. She is highly regarded for her fixed income capital marketing skills across Asia and the United States. Ms. Lam has over 25 years of experience in the financial markets industry, dealing with many asset classes and clients. Having spent a few years in the fintech startup industry, her skills bridge the gap between traditional financial assets and new technological innovations. She has held senior management positions at Bear Sterns, Deutsche Bank and Standard Chartered Bank.

Keith Byers is Ideanomics’ Senior Vice President of Operations. He has extensive experience managing strategic relationships with key clients and deepening the relationships through innovation and successful engagement strategies. Before Ideanomics, Mr. Byers was the Managing Partner and Head of Operations for Gain Theory. He has a Master of Arts – MA, Economics from Heriot-Watt University and a Master of Science – Economics from The University of Edinburgh.

Tony Sklar is the company’s Senior Vice President of Investor Relations. He is a communication strategist and has worked for multi-faceted companies with global operations. Mr. Sklar handles omni-channel distribution using intelligence platforms and data insights for strategic planning, international expansion and marketing channels. His specialties include project management with digital strategy and transformation, ICO, marketing, blockchain and strategic partnerships. In addition to his role with Ideanomics, he is also a board member for the Delaware Board of Trade and the host and senior technology reporter for Far From TV.

Ideanomics Inc. (IDEX), closed Wednesday’s trading session at $2.38, off by 3.252%, on 11,033,354 volume. The average volume for the last 3 months is 19.413M and the stock's 52-week low/high is $0.800000011/$5.5300002.

Recent News

Splash Beverage Group Inc. (OTCQB: SBEV)

The QualityStocks Daily Newsletter would like to spotlight Splash Beverage Group Inc. (OTCQB: SBEV).

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today announced that it has integrated Oracle’s NetSuite software into its Qplash ecommerce sales and distribution platform. The integration has worked to fully automate the platform’s systems from order to shipment. “We are building out Qplash with best-in-class systems that enable us to optimize margins and accelerate the rollout of our current brands both to distributors and direct to consumers,” said Splash CEO Robert Nistico. “While continuing to build partnerships with the largest beverage distributors in the U.S. and internationally, Splash is pursuing a vertically integrated business strategy through Qplash to incubate and launch new brands as well as test marketing them, which can build momentum for future acquisitions. Creating retail demand online, we can then migrate a growing portfolio of brands from ecommerce to traditional retail outlets in line with our multichannel strategy.” To view the full press release, visit https://ibn.fm/jMPJo

Splash Beverage Group Inc. (OTCQB: SBEV) is a portfolio company of successful beverage brands with the objective of driving value through superior production, supply chain efficiency and global distribution capabilities.

Specializing in manufacturing, distributing, sales & marketing of various beverages across multiple channels, the company operates in both the alcoholic and non-alcoholic beverage segments, allowing it to leverage efficiencies and dilute risk. The company’s business strategy is to quickly develop and/or accelerate pre-existing brands to exit for cash events. Led by a highly successful management team, the company only works with brands it perceives to have highly visible preexisting brand awareness or pure category innovation, thus breaking through the clutter. Splash seeks out brands offering products that:

  • Deliver natural quality, health benefits, freshness and refreshment within their beverages;
  • Are on trend with consumers;
  • Have a high level of brand awareness;
  • Maintain highest performance standards and focus on execution;
  • Help distributors and retail partners achieve and exceed all goals; and
  • Offer unapologetic support for members of the U.S. armed forces, first responders and health care professionals.

Splash was founded in 2013 and is located in Fort Lauderdale, Florida.

Splash Portfolio

The current Splash portfolio includes four unique beverage brands. Each of these brands offers one or more of the qualities that the company specifically seeks in an acquisition.

  • TapouT Performance is a natural isotonic hydration & recovery sport drink featuring a 3-in-1 advanced formula. TapouT Performance restores what the body loses through physical exertion, delivering hydration and cellular recovery. Perfectly balanced with key vitamins & minerals and all five necessary electrolytes, TapouT increases nutrient absorption, allowing the body to recover quickly and more efficiently. TapouT is the official training partner of the WWE (NYSE: WWE).
  • Salt Naturally Flavored Tequila is a 100% blanco agave 80 proof tequila that offers a clean and delicate taste. Salt is grown, distilled and bottled in the Jalisco region of Mexico. Every bottle of Salt Tequila is the result of hard work, determination and numerous blends. The brand offers a line of tequila flavors for enhanced refreshment, including berry, citrus and salted chocolate.
  • Copa Di Vino is the leading producer of premium “wine by the glass” in the U.S. Produced in the Columbia Valley, Copa di Vino is readily available on the go without the requirement of a bottle, corkscrew or glass. Open, drink and enjoy.
  • Pulpoloco Sangria is a premium crafted sangria imported from Spain. Its flavor is light-bodied, fruity and refreshing, offering the best blend of Spanish ingredients. The product is filled and packed in a unique eco-friendly biodegradable catocan, allowing Pulpoloco to extend the shelf life of the sangria without the use of preservatives.

Market Outlook

The global beverage industry was valued at $1.5 trillion in 2018 and is projected to grow at a CAGR of 3.1%, reaching a market size of $1.9 trillion by 2024 (https://nnw.fm/w1Cx9). The push for non-alcoholic beverages that are healthier and contain zero sugar is expected to be a driving force in the forecast period and beyond.

With a seasoned management team and sufficient capital to fuel sustained growth, Splash is uniquely positioned to capitalize on this market growth. The company is currently preparing a secondary offering and has engaged Kingswood Capital Markets as lead underwriter in order to uplist to the Nasdaq or NYSE in the near future.

Management Team

Robert Nistico is the Chairman and CEO of Splash Beverage Group. He has 28 years of experience in the beverage industry and was the fifth employee and SVP/General Manager of Red Bull North America. In this role, he led the start-up from zero sales to $1.65 billion in annual sales. Mr. Nistico was a founder and President of Marley Beverages and was responsible for framing the company’s long-term vision. Mr. Nistico held executive positions at DIAGEO, Republic National Distributing Company and the Gallo Wine Company resulting in decades of successful experience in the ‘Three Tier Beverage System’. In the spirit of his true entrepreneurial nature, he is a motivated, results-driven, creative and passionate leader.

William Meissner is the company’s President and CMO. He boasts over 20 years of success in growing consumer brand companies with large and medium-sized entrepreneurial organizations, both locally and internationally. His résumé includes multiple CEO roles, leading efforts to revamp both healthy and distressed companies. Before joining Splash, Mr. Meissner was the President and CEO of Sweet Leaf and Tradewinds Tea. He has held multiple positions with leading companies in the beverage sector, including Sparkling Ice, Jones Soda, SoBe Beverages, Fuze & NOS (Coca-Cola) and many others.

Sanjeev Javia is the Vice President of Product Development for Splash. He is the founder and President of Javia Wellness Group, a firm focusing on the innovation, research, formulation and design of healthy exercise and wellness initiatives. Mr. Javia is a sports nutrition expert, allowing him the advantage of developing innovative functional beverages that include health benefits for consumers. Since 2000, he has advised and written nutritional plans for hundreds of the world’s most famous athletes, including Tom Brady, Kurt Warner, Curt Schilling and more.

Dean Huge is the company’s Chief Financial Officer. He brings 35 years of public and private sector accounting and finance experience to the Splash Beverage team. Mr. Huge has led four public offerings as CFO and guided the growth efforts of numerous companies, including Catalyst Energy Corp., which was named Inc. Magazine’s ‘Fastest Growing Company’ within 36 months of his joining. His expertise spans financial services, manufacturing, distribution and SAAS-type programs.

Aida Aragon is the company’s Senior Vice President of National Accounts. She is a sales, marketing and brand management executive with years of experience working in the sports supplement and beverage industry. In her previous positions, Ms. Aragon was vital in leading successful store rollouts for brands including Muscle Milk. Her passion for brand development comes as second nature, but her true passion has always been focused on increasing sales for brands in the sports nutrition industry.

Splash Beverage Group Inc. (SBEV), closed Wednesday’s trading session at $3.4107, off by 7.5691%, on 585,458 volume. The average volume for the last 3 months is 316,775 and the stock's 52-week low/high is $1.55999994/$15.3000001.

Recent News

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI (R) Stick disposable electronic nicotine delivery system ("ENDS"), which is intended exclusively for adults 21 and over. Today the company announced its plans to launch a Kaival-branded hemp CBD product line. “I am excited to announce the upcoming launch of our new, lab-developed, proprietary CBD products,” said Niraj "Raj" Patel, founder and CEO of Kaival Brands. “Our mission is to set new industry standards by providing the highest quality and most effective products in the hemp CBD marketplace. Our focus is to help people improve their lives by providing a product that maximizes the potential health benefits hemp CBD has to offer.” To view the full press release, visit https://ibn.fm/aSuL2

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Wednesday’s trading session at $0.65, off by 4.6921%, on 74,357 volume. The average volume for the last 3 months is 144,674 and the stock's 52-week low/high is $0.228300005/$3.65000009.

Recent News

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

Earlier in February this year, the price of copper rose to a nine-year high driven by the rush of speculative investment, expectations of tight supply and resurgent demand in China, the largest consumer of the metal. This trend continued in the months that followed, with the demand for copper rising in April when the U.S. dollar declined in value. In May, copper for delivery had increased by almost 2%, with futures at $9351 per ton on the Comex market. As recent as this week, the price of the red metal rose again, driven by hopes that the demand for metals will grow as more hires take place across the United States. These rising copper prices are likely to give sector players such as Asia Broadband Inc. (OTC: AABB) impetus to ramp up its operations since the market is seen as being bullish for the years ahead.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance www.AABBGoldToken.com, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Wednesday’s trading session at $0.12225, off by 2.9762%, on 14,846,225 volume. The average volume for the last 3 months is 22.224M and the stock's 52-week low/high is $0.0026/$0.658999979.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading